SAN FRANCISCO & CHICAGO--(BUSINESS WIRE)--Promising results from a pilot program using a generative AI platform to help with clinical documentation show improvements in both patient and clinician experiences at the University of Chicago Medicine, according to survey data of patients at the academic health system. UChicago Medicine will expand the program to more than 800 clinicians across its health system.
Over a six-week period, about 200 UChicago Medicine physicians used Abridge’s technology to transform medical conversations into structured clinical documentation in real time, capturing conversations with patients. Patients were surveyed during the pilot by Press Ganey, the leading provider of experience measurement, data analytics, and insights to health systems. Key findings revealed improvements across multiple areas of patient experience, including:
- 4.4 percentage point increase in “concern shown by the provider”
- 3.6 point increase in satisfaction with “explanations about the patient’s problem or condition”
- 3.0 point increase in the perception that they are “included in care decisions”
“This shows that technology has the power to ease burdens that our clinician colleagues have been experiencing,” said Dr. Sachin Shah, Chief Medical Information Officer at UChicago Medicine. “Half a percent increase year-over-year in these scores is generally considered an accomplishment—we saw nearly an eight-fold improvement over that standard in just six weeks.”
According to a study surveying clinicians prior to the pilot and then following 30 days of use:
- 90% agree that the introduction of Abridge makes them feel more valued by UChicago Medicine
- 90% of clinicians provided undivided attention to patients (up from 49% before Abridge)
“We’re seeing the direct impact of a more focused patient-clinician conversation in improving clinician satisfaction and a better overall patient experience,” said Dr. Shiv Rao, CEO and Founder of Abridge. “We’re looking forward to our continued partnership with UChicago Medicine to scale the platform across all specialties.”
In a recent report from healthcare industry research and insights firm KLAS about the most promising emerging technologies, Abridge was ranked No. 1 for “Improving Clinician Experience,” No. 3 for “Improving Patient Experience,” and No. 4 for “Improving Outcomes.” KLAS examined dozens of new healthcare technology vendors, and the rankings were determined by a panel of 49 industry experts.
Abridge is rapidly becoming the platform of choice for enterprise-wide deployment at leading healthcare systems across the country, including Corewell Health, Riverside Health, Reid Health, University of Vermont Health Network, CHRISTUS Health, Sutter Health, Yale New Haven Health System, UCI Health, Emory Healthcare, The University of Kansas Health System, UPMC, and many more. Recently, Mayo Clinic, Epic, and Abridge partnered on a generative AI ambient documentation workflow for nurses. Abridge has also formed partnerships with Wolters Kluwer, OpenNotes, and other leading healthcare organizations to enrich the Abridge platform ecosystem. Earlier this year, Abridge announced a $150M Series C financing, which includes a strategic investment from NVIDIA.
About Abridge
Abridge was founded in 2018 to power deeper understanding in healthcare. The AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. With support for 28+ languages and 50+ specialties, Abridge is able to support a wide range of clinician and patient encounters.
Abridge’s enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time with deep EMR integrations. Powered by Linked Evidence and their auditable AI, Abridge is the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, Abridge is setting the industry standards for the responsible deployment of AI across health systems.
Abridge was also recently recognized on the 2024 Forbes AI 50 list, alongside companies like OpenAI, Anthropic, Databricks, and others.
